A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial-Reference-Cited by-同舟云学术

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial

Published:2014-02-19 Issue: Volume:113 Page:7-12
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Pearse Maria¹,Fraser-Browne Carol²,Davis Ian D.³,Duchesne Gillian M.⁴,Fisher Richard⁵,Frydenberg Mark⁶,Haworth Annette⁷,Jose Chakiath¹,Joseph David J.⁸,Lim Tee S.⁹,Matthews John¹,Millar Jeremy¹⁰,Sidhom Mark¹¹,Spry Nigel A.⁸,Tang Colin I.⁸,Turner Sandra¹²,Williams Scott G.⁴,Wiltshire Kirsty⁴,Woo Henry H.¹³,Kneebone Andrew¹⁴

Affiliation:

1. Department of Radiation Oncology; Auckland City Hospital; Auckland New Zealand

2. Cancer and Blood Research; Auckland City Hospital; Auckland New Zealand

3. Eastern Health Clinical School; Monash University; Melbourne VIC Australia

4. Department of Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne VIC Australia

5. Centre for Biostatistics and Clinical Trials; Peter MacCallum Cancer Centre; Melbourne VIC Australia

6. Department of Physics; Peter MacCallum Cancer Centre; Melbourne VIC Australia

7. Department of Urology; Monash Medical Centre; Melbourne VIC Australia

8. Department of Radiation Oncology; Sir Charles Gairdner Hospital; Nedlands Australia

9. Department of Radiation Oncology; Royal Perth Hospital; Perth WA Australia

10. Department of Radiation Oncology; Alfred Health; Melbourne VIC Australia

11. Department of Radiation Oncology; Liverpool Hospital; Sydney NSW Australia

12. Radiation Oncology Network; Westmead and Nepean Hospitals; Sydney NSW Australia

13. Sydney Adventist Hospital Clinical School; University of Sydney; Sydney NSW Australia

14. Northern Sydney Cancer Centre; Sydney NSW Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12623/fullpdf

Reference14 articles.

1. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2012

2. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial;Thompson;J Urol,2009

3. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95;Wiegel;J Clin Oncol,2009

4. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group;Sidhom;Radiother Oncol,2008

5. Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03);Sundaresan;Radiother Oncol,2011

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasets;Computerized Medical Imaging and Graphics;2024-09

2. Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve Patients;Life;2024-07-11

3. Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer;Cancers;2024-05-14

4. Evaluating the relationship between contouring variability and modelled treatment outcome for prostate bed radiotherapy;Physics in Medicine & Biology;2024-04-03

5. Urinary Continence Recovery after Retzius-Sparing Robot Assisted Radical Prostatectomy and Adjuvant Radiation Therapy;Cancers;2023-09-01